Jase, I think you could be right on the money. Ibuprofen delivery using this microneedle invention is viable and game-changing.
Anyone circling around this trying to understand where OBJ is at, this research note outlines the state of OBJ tech very well;
https://www.bakeryoung.com.au/wp-content/uploads/2016/08/BY-OBJ-Research-Note.pdf
(if you're going to comment that that broker appears to be selling, you would be right - but please appreciate that brokers prey on sentiment and have very short-term focus. There are many products from OBJ that are already confirmed to be heading to market. Take a particular look at BeautyConnect if you want to see how P&G and OBJ are going to transform the cosmetic industry).
All the best
Matt
- Forums
- ASX - By Stock
- WFL
- Ann: Pharmaceutical Clinical Study Commences
Ann: Pharmaceutical Clinical Study Commences, page-44
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online